Dr. Marc Brisson is full professor at Laval University where he leads the Research Group in Mathematical Modeling and Health Economics of Infectious Diseases. His research aims at developing mathematical models that predict the effectiveness and cost-effectiveness of interventions against infectious diseases to help policy decision-making. His current research mainly focuses on human papillomavirus and varicella-zoster-virus vaccines. Dr. Brisson has produced over 100 peer reviewed journal articles (including high impact journals such as The Lancet and The Lancet Family, JNCI, BMJ, and Annals of Internal Medicine), and made over 110 presentations at conferences, external seminars and workshops (over 60 as invited speaker). He has consulted for the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the Canadian Partnership Against Cancer (CPAC), the Public Health Agency of Canada (PHAC) and the Canadian Immunization Committee (CIC). He has a BSc in Actuarial Science (1992-1996), a certificate in Statistics (1996) and an MSc in Epidemiology (1996-2001) from Laval University in Quebec City, and a PhD in Health Economics (1999-2004) from City University in London, England.